6-HYDROXY-4-OXO-1,4-DIHYDROPYRIMIDINE-5-CARBOXAMIDES AS APJ AGONISTS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20170275272A1
公开(公告)日:2017-09-28
The present invention provides compounds of Formula (I):
wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.
[EN] APELIN RECEPTOR AGONISTS AND METHODS OF USE<br/>[FR] AGONISTES DU RÉCEPTEUR DE L'APÉLINE ET LEURS MÉTHODES D'UTILISATION
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2017096130A1
公开(公告)日:2017-06-08
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.
In this study, lipase-mediated dynamickineticresolution (DKR) of various benzylic amines (1a–g) is presented which is realized in a so far unprecedented fully continuous-flow system. The DKR process applying sol–gel immobilized lipase B from Candidaantarctica as biocatalyst, palladium on 3-aminopropyl-functionalized silica as racemization catalyst, isopropyl 2-ethoxyacetate as acylating agent, ammonium